•
Sep 30, 2014

PTC Therapeutics Q3 2014 Earnings Report

Total Revenue
$1.69M
Previous year: $16.3M
-89.6%
EPS
-$0.93
Previous year: -$0.19
+389.5%
Cash and Equivalents
$52.9M
Previous year: $24M
+119.9%
Total Assets
$221M
Previous year: $167M
+32.0%

PTC Therapeutics

PTC Therapeutics